Tharimmune Stock Soars 30% After $540M Raise, Plans Digital Coin Treasury – You Won’t Believe It!

Tharimmune (THAR), that little Nasdaq-listed biotech company you probably never heard of until now, has raised around $540 million in a private placement. It was all led by DRW and Liberty City Ventures. The firm is apparently having a big pivot moment, aiming to build a digital asset treasury (DAT) strategy around the mysterious and slightly elusive canton coin (CC). Yes, it’s real. (They’re serious, don’t worry.)



